Undisclosed Round

Celgene-backed immuno-oncology drug developer Dragonfly Therapeutics boosted its total financing to $300m in round of undisclosed size led by Fidelity.

Celgene-backed Nurix Therapeutics will use the capital to advance two protein modulation-based immuno-oncology drug candidates toward clinical trials.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The antibody therapy developer closed a $100m round co-led by Lilly Asia Ventures that will fund phase 3 clinical studies for its lead drug candidates.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

George Health Enterprises and its subsidiary George Medicines have raised a combined $35m in funding from investors including Bupa Australia to drive pipeline development and commercialisation.

Naspers subsidiary OLX Group led a $120m round for the e-commerce app developers, which have agreed to merge, and will own 40% of the combined entity.

The round increased the total raised by the Alibaba, Sony, WndrCo,21st Century Fox, Walt Disney, WarnerBros and Entertainment One-backed short-form streaming startup to $1.75bn.

Autonomous car developer Waymo has snatched up its first external funding, with parent company Alphabet, Magna International and AutoNation all investing.

Cargo shipping services platform Flexport is now valued at $3.2bn following a $1bn round led by SoftBank Vision Fund that will go to technology development and hiring.